Experimental Hematology
Volume 35, Issue 4 , Pages 534-540, April 2007

Yttrium-90–ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma

  • Avichai Shimoni

      Affiliations

    • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
    • Corresponding Author InformationOffprint requests to: Avichai Shimoni, M.D., Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • S. Tzila Zwas

      Affiliations

    • Department of Nuclear Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • Yakov Oksman

      Affiliations

    • Department of Nuclear Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • Izhar Hardan

      Affiliations

    • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • Noga Shem-Tov

      Affiliations

    • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • Ronit Yerushalmi

      Affiliations

    • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • Abraham Avigdor

      Affiliations

    • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • Isaac Ben-Bassat

      Affiliations

    • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
  • ,
  • Arnon Nagler

      Affiliations

    • Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel

Received 29 October 2006; received in revised form 19 December 2006; accepted 18 January 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(07)00050-1

doi:10.1016/j.exphem.2007.01.043

Experimental Hematology
Volume 35, Issue 4 , Pages 534-540, April 2007